⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14793644 | 0.80 | — | — | |
| SCHEMBL3148463 | 0.67 | — | — | |
| SCHEMBL14793495 | 0.63 | — | — | |
| SCHEMBL3148368 | 0.63 | — | — | |
| SCHEMBL143917 | 0.63 | — | — | |
| SCHEMBL8552885 | 0.63 | — | — | |
| SCHEMBL2042013 | 0.61 | — | — | |
| SCHEMBL8884963 | 0.60 | — | — | |
| SCHEMBL3357209 | 0.60 | — | — | |
| SCHEMBL545786 | 0.58 | HKDC1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3284832-B1 | APTAMER WITH IMPROVED RATE OF DISSOCIATION, AND NON-COVALENT APTAMER-TARGET COMPLEX THEREOF | SOMALOGIC OPERATING CO INC (US) | 2023-06-07 | — | — | EP | claimed |
| EP-3284832-A2 | METHOD FOR GENERATING APTAMERS WITH IMPROVED OFF-RATES | Somalogic, Inc. (US) | 2018-02-21 | — | — | EP | claimed |
| EP-2933340-B1 | Aptamers with uridines and/or thymidines substituted at the 5-position with a benzyl group | SOMALOGIC INC (US) | 2017-09-06 | — | — | EP | claimed |
| US-20170137819-A1 | Method for Generating Aptamers with Improved Off-Rates | SOMALOGIC, INC. | 2017-05-18 | — | — | US | claimed |
| EP-2933340-A1 | Chemically modified aptamers with improved off-rates | Somalogic, Inc. (US) | 2015-10-21 | — | — | EP | claimed |
| US-20150197753-A1 | Method for Generating Aptamers with Improved Off-Rates | SOMALOGIC, INC. | 2015-07-16 | — | — | US | claimed |
| US-8975388-B2 | Method for generating aptamers with improved off-rates | SOMALOGIC, INC. (US) | 2015-03-10 | — | — | US | claimed |
| US-8404830-B2 | Method for generating aptamers with improved off-rates | SOMALOGIC, INC. (US) | 2013-03-26 | — | — | US | claimed |
| EP-0719273-B1 | NUCLEOTIDE ANALOGS | GILEAD SCIENCES INC (US) | 2010-11-03 | — | — | EP | claimed |
| US-20040242465-A1 | Nucleotide analogs | BISCHOFBERGER NORBERT W (US) | 2004-12-02 | — | — | US | claimed |
| US-20040014722-A1 | Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases | BIOCRYST PHARMACEUTICALS, INC. | 2004-01-22 | — | — | US | claimed |
| US-20010041794-A1 | Nucleotide analogs | GILEAD SCIENCES, INC. | 2001-11-15 | — | — | US | claimed |
| US-6225460-B1 | PHOSPHOAMIDATE OR ESTER BOND THAT IS HYDROLYZED IN VIVO TO YIELD A CORRESPONDING PHOSPHONATE NUCLEOTIDE ANALOG. | GILEAD SCIENCES, INC. | 2001-05-01 | — | — | US | claimed |
| US-5656745-A | AMIDATE LINKAGE; ANTITUMOR, ANTICARCINOGENIC AGENTS | GILEAD SCIENCES, INC. (US) | 1997-08-12 | — | — | US | claimed |
| US-8404830-B2 | Method for generating aptamers with improved off-rates | SOMALOGIC, INC. (US) | 2013-03-26 | — | — | US | disclosed |
| EP-0719273-B1 | NUCLEOTIDE ANALOGS | GILEAD SCIENCES INC (US) | 2010-11-03 | — | — | EP | disclosed |
| WO-2004106350-A1 | NUCLEOSIDE ANALOGS AS VIRAL POLYMERASE INHIBITORS | BIOCRYST PHARMACEUTICAL, INC. (US) | 2004-12-09 | — | — | WO | disclosed |
| US-20040014722-A1 | Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases | BIOCRYST PHARMACEUTICALS, INC. | 2004-01-22 | — | — | US | disclosed |